D
David Gordon
Researcher at University of Iowa
Publications - 255
Citations - 36058
David Gordon is an academic researcher from University of Iowa. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 76, co-authored 225 publications receiving 33730 citations. Previous affiliations of David Gordon include Harvard University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
Curt D. Furberg,Jackson T. Wright,Barry R. Davis,Jeffrey A. Cutler,Michael H. Alderman,Henry R. Black,William C. Cushman,Richard H. Grimm,L. Julian Haywood,Frans H. H. Leenen,Suzanne Oparil,Jeffrey L. Probstfield,Paul K. Whelton,Chuke Nwachuku,David Gordon,Michael A. Proschan,Paula Einhom,Charles E. Ford,Linda B. Piller,I. Kay Dunn,David C. Goff,Sara L. Pressel,Judy Bettencourt,Barbara DeLeon,Lara M. Simpson,Joe Blanton,Therese S. Geraci,Sandra M. Walsh,Christine Nelson,Mahboob Rahman,Anne Juratovac,Robert Pospisil,Lillian Carroll,Sheila Sullivan,Jeanne Russo,Gail Barone,Rudy Christian,Sharon Feldman,Tracy Lucente,David A. Calhoun,Kim Jenkins,Peggy McDowell,Janice Johnson,Connie Kingry,Juan Alzate,Karen L. Margolis,Leslie Ann Holland-Klemme,Brenda Jaeger,Jeff D. Williamson,Gail T. Louis,Pamela Ragusa,Angela Williard,R. L Sue Ferguson,Joanna Tanner,John H. Eckfeldt,Richard S. Crow,John Pelosi +56 more
TL;DR: Thiazide-type diuretics are superior in preventing 1 or more major forms of CVD and are less expensive and should be preferred for first-step antihypertensive therapy.
Journal ArticleDOI
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
David Gordon,Jeffrey L. Probstfield,Robert J. Garrison,James D. Neaton,William P. Castelli,J. D. Knoke,David R. Jacobs,Shrikant I. Bangdiwala,H. A. Tyroler +8 more
TL;DR: A consistent inverse relation of high-density lipoprotein cholesterol levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.
Journal Article
Diagnosis and management of the metabolic syndrome
Scott M. Grundy,James I. Cleeman,Stephen R. Daniels,Karen A. Donato,Robert H. Eckel,Barry A. Franklin,David Gordon,Ronald M. Krauss,Peter J. Savage,Sidney C. Smith,John A. Spertus,Fernando Ferreira Costa +11 more
Journal ArticleDOI
High-Density Lipoprotein — The Clinical Implications of Recent Studies
David Gordon,Basil M. Rifkind +1 more
TL;DR: A large number of animal studies have shown an association between serum levels of high-density lipoprotein (HDL) cholesterol and coronary disease, and the possible protective role of HDL in athero...
Journal ArticleDOI
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women's Health Study: A Randomized Controlled Trial
I-Min Lee,Nancy R. Cook,J. Michael Gaziano,David Gordon,Paul M. Ridker,JoAnn E. Manson,Charles H. Hennekens,Julie E. Buring +7 more
TL;DR: The data from this large trial indicated that 600 IU of natural-source vitamin E taken every other day provided no overall benefit for major cardiovascular events or cancer, did not affect total mortality, and decreased cardiovascular mortality in healthy women.